New eye drops show promise for dry eye sufferers
NCT ID NCT06544694
First seen Apr 06, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study tested a new eye drop called AR-15512 in 80 adults with dry eye disease. The goal was to see if the drops could improve the health of the eye's surface, specifically by increasing the number of goblet cells that help keep the eye moist. Participants used the drops for 90 days, and the study measured changes in their eye cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Butchertown Clinical Trials
Louisville, Kentucky, 40206, United States
-
CORE, Inc.
Shelby, North Carolina, 28150, United States
-
Oculus Research
Garner, North Carolina, 27529, United States
-
Wilmington Eye
Leland, North Carolina, 28451, United States
Conditions
Explore the condition pages connected to this study.